AstraZeneca says its COVID vaccine "highly effective" in late trials
It's third drugmaker to report such results in two weeks. AstraZeneca developed its vaccine along with Oxford University.
Full Article
AstraZeneca says its COVID vaccine "highly effective" in late trials
CBS News
0 shares
2 views
You might like
Related news coverage
AstraZeneca to launch a new global trial for its COVID-19 vaccine
Invezz
In a statement on Thursday, CEO Pascal Soriot of AstraZeneca plc (LON: AZN) expressed plans of launching a new global trial that..
-
NA Proactive news snapshot: Milestone Scientific, Loncor Resources, LeanLife, Genprex, BioSig Technologies UPDATE...
Proactive Investors
-
Coronavirus: UK expected to approve Pfizer/BioNTech vaccine this week, acquires 2mln extra doses of Moderna jab
Proactive Investors
-
AstraZeneca says "dosing error" resulted in boosted vaccine trial outcome, justifying claims of "90 percent effective"
NaturalNews.com
-
Germany prepares to roll out vaccines soon, as cases hit 1 million
Mid-Day
Advertisement
More coverage
AstraZeneca manufacturing error clouds Oxford vaccine study results
Mid-Day
AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary..
-
UK asks regulator to assess AZ-Oxford vaccine amid questions
SeattlePI.com
-
AstraZeneca-Oxford COVID vaccine safe, Indian trials progressing smoothly: Serum Institute
Zee News
-
India to consider clinical trials data of two full doses of AstraZeneca vaccine
IndiaTimes
-
AstraZeneca-Oxford vaccine safe, Indian trials progressing smoothly: Serum Institute
IndiaTimes